Pamidronate decreases tumor-induced osteoclastogenesis in osteopetrotic mice

Denis R Clohisy, Patrick F. O'Keefe, Margaret L. Ramnaraine

Research output: Contribution to journalArticle

27 Scopus citations

Abstract

Recent studies indicate that the bisphosphonate pamidronate reduces skeletal complications caused by tumor osteolysis. In this investigation, the cellular mechanism through which pamidronate affects tumor-induced osteoclastogenesis is studied in osteopetrotic mice. A unique animal model is employed which studies the effect of pamidronate on a tumor (2472 sarcoma) which induces osteoclastogenesis in osteoclast-deficient mice (oplop). This model provides opportunity to specifically study effects on osteoclast formation and findings suggest that pamidronate decreases the number of osteoclasts at sites of 2472 tumor by decreasing the number of osteoclast precursor cells at the level of myeloid precursors.

Original languageEnglish (US)
Pages (from-to)554-558
Number of pages5
JournalJournal of Orthopaedic Research
Volume19
Issue number4
DOIs
StatePublished - Jan 1 2001

    Fingerprint

Cite this